Thromboxane Generation in Patients with Essential Hypertension or Cerebrovascular Disease and Effect of Oral Aspirin
- 1 January 1980
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 44 (01), 016-022
- https://doi.org/10.1055/s-0038-1650072
Abstract
The ability of platelets to synthesize thromboxane B2 (TxB2) from arachidonic acid (AA) or prostaglandin H2 (PGH2) was studied in 26 control subjects, 40 patients with essential hypertension, 20 patients with cerebrovascular disease (CVD) not taking aspirin and 11 patients with CVD taking aspirin. The activity of platelets to form TxB2 from AA or PGH2 was measured using 1 — 14C arachidonic acid or 1—14C PGH2 as a substrate. There was no significant difference in TxB2 generation from AA or PGH2 among the platelets collected from the control subjects, hypertensive patients and CVD patients not taking aspirin. In CVD patients taking aspirin, marked suppression was observed in TxB2 synthesis from AA, but no suppression in TxB2 synthesis from PGH2. At least 750 mg aspirin per day were required for nearly complete suppression of TxB2 generation from AA.Keywords
This publication has 16 references indexed in Scilit:
- Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazolesProstaglandins, 1978
- Platelet aggregation studies in coronary artery diseaseAtherosclerosis, 1978
- Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive ratProstaglandins, 1978
- Inhibition of platelet prostaglandin synthetase by oral aspirin.JCI Insight, 1978
- PLATELET ACTIVATION IN ACUTE CEREBRAL ISCHÆMIAThe Lancet, 1977
- PLATELET AGGREGATION AND FIBRINOLYTIC ACTIVITY IN TRANSIENT CEREBRAL ISCHEMIAActa Neurologica Scandinavica, 1977
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregationProstaglandins, 1976
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Platelet aggregability measured by screen filtration pressure method in cerebrovascular diseases.Stroke, 1976